Lancaster Radiation Oncology

Az itteni vizsgálatok

Miről szól a helyszín 20 vizsgálata, a regiszteri adatlapjaik szerint.

Betegségek

• Melanóma3 vizsgálat
• Mielóma multiplex3 vizsgálat
• Hasnyálmirigyrák2 vizsgálat
• Krónikus limfoid leukémia (CLL)2 vizsgálat
• Petefészekrák2 vizsgálat
• Vesedaganat2 vizsgálat
• Áttétes emlőrák1 vizsgálat
• Fej-nyaki daganatok1 vizsgálat
• Gyermekkori daganatok1 vizsgálat
• Méhnyakrák1 vizsgálat
• Neuroendokrin daganatok1 vizsgálat
• Tüdőrák1 vizsgálat
• és még 1

Fázis

• 3. fázis14 vizsgálat
• 2. fázis4 vizsgálat
• 1/2. fázis1 vizsgálat
• 2/3. fázis1 vizsgálat

Állapot

• Fut, nem toboroz10 vizsgálat
• Lezárult10 vizsgálat

Fő szponzor

• National Cancer Institute (NCI)13 vizsgálat
• SWOG Cancer Research Network3 vizsgálat
• ECOG-ACRIN Cancer Research Group2 vizsgálat
• Alliance for Clinical Trials in Oncology1 vizsgálat
• GOG Foundation1 vizsgálat

Futó vizsgálatok

• Fut, nem toboroz

  Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

  NCT02048813· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Rituximab and Bendamustine Hydrochloride, Rituximab and Ibrutinib, or Ibrutinib Alone in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia

  NCT01886872· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

  NCT01863550· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Fut, nem toboroz

  Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

  NCT01841736· 2. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  S0820, Adenoma and Second Primary Prevention Trial

  NCT01349881· 3. fázis· SWOG Cancer Research Network· Forrás

• Fut, nem toboroz

  Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery

  NCT01575548· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

  NCT01274338· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma

  NCT01169337· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT00588770· 3. fázis· National Cancer Institute (NCI)· Forrás

• Fut, nem toboroz

  Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

  NCT00565851· 3. fázis· National Cancer Institute (NCI)· Forrás

Lezárt vizsgálatok

• Lezárult

  Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

  NCT02101788· 2/3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

  NCT02003209· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

  NCT01950390· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors

  NCT01824875· 2. fázis· ECOG-ACRIN Cancer Research Group· Forrás

• Lezárult

  Ipilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

  NCT01708941· 2. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  S1211 Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma

  NCT01668719· 1/2. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

  NCT01120249· 3. fázis· SWOG Cancer Research Network· Forrás

• Lezárult

  Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

  NCT01101451· 3. fázis· GOG Foundation· Forrás

• Lezárult

  Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery

  NCT01013649· 3. fázis· National Cancer Institute (NCI)· Forrás

• Lezárult

  Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide

  NCT00632853· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás